KAITLIN CAVANAGH: Open Payments
NPI 1144840703 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 23 payments from 10 companies in 2025. Trend: 2023 $348 · 2024 $419 · 2025 $1,055
Food & beverage: $1,055
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $350 |
| Janssen Biotech, Inc. | 5 | $188 |
| LEO Pharma Inc. | 1 | $121 |
| Lilly USA, LLC | 3 | $87 |
| Arcutis Biotherapeutics, Inc. | 2 | $86 |
| ABBVIE INC. | 1 | $77 |
| UCB, Inc. | 1 | $49 |
| GENZYME CORPORATION | 1 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| MIMEDX Group, Inc. | 1 | $24 |
Products named: OPZELURA, TREMFYA, ANZUPGO, TALTZ, SKYRIZI, DUPIXENT, Bimzelx, Zoryve.
Industry payments across IL — which companies pay providers there.
